Fuji Soft, Bain Capital and KKR
10d
Dealbreaker on MSNBain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe PharmaBain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results